Shandong Boyuan Pharmaceutical & Chemical Co., Ltd. (SHE:301617)
73.64
+0.19 (0.26%)
At close: Feb 13, 2026
SHE:301617 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Cash & Equivalents | 326.8 | 957.84 | 228.52 | 80 | 46.5 | 19.86 |
Trading Asset Securities | 435 | - | - | 69.15 | 23.52 | 5 |
Cash & Short-Term Investments | 761.8 | 957.84 | 228.52 | 149.15 | 70.02 | 24.86 |
Cash Growth | 145.49% | 319.15% | 53.22% | 112.99% | 181.71% | -37.52% |
Accounts Receivable | 196.13 | 182.43 | 169.27 | 121.25 | 105.25 | 111.3 |
Other Receivables | 1.62 | 1.63 | 4.7 | 0.74 | 2.43 | 8.73 |
Receivables | 197.75 | 184.06 | 173.97 | 121.99 | 107.67 | 120.03 |
Inventory | 297.27 | 210.39 | 171.37 | 137.1 | 104.03 | 76.53 |
Prepaid Expenses | - | - | - | 0.47 | - | - |
Other Current Assets | 60.93 | 25.62 | 21.02 | 11.72 | 28.17 | 10.73 |
Total Current Assets | 1,318 | 1,378 | 594.88 | 420.43 | 309.89 | 232.15 |
Property, Plant & Equipment | 484.74 | 436.96 | 369.2 | 331.44 | 187.82 | 159.2 |
Other Intangible Assets | 60.92 | 55.23 | 56.54 | 58.32 | 58.01 | 20.41 |
Long-Term Deferred Tax Assets | 0.98 | 0.69 | 0.67 | 0.36 | 0.72 | 0.68 |
Other Long-Term Assets | 10.78 | 1.22 | 1.72 | 1.1 | 2.58 | 6.39 |
Total Assets | 1,875 | 1,872 | 1,023 | 811.65 | 559.02 | 418.84 |
Accounts Payable | 129.56 | 161.85 | 143.08 | 134.32 | 51.92 | 59.02 |
Accrued Expenses | 10.2 | 21.11 | 14.94 | 15.7 | 13.42 | 8.5 |
Short-Term Debt | 0.95 | - | - | 1 | 0.38 | 28.47 |
Current Portion of Leases | 0.07 | 0.27 | 0.26 | 0.97 | 1.1 | - |
Current Income Taxes Payable | 4.96 | 7.03 | 4.71 | 2.33 | 4.39 | - |
Current Unearned Revenue | 2.77 | 4.01 | 4.39 | 2.86 | 4.4 | 2.35 |
Other Current Liabilities | 37.71 | 27.81 | 46.78 | 26.36 | 31.72 | 23.57 |
Total Current Liabilities | 186.21 | 222.08 | 214.16 | 183.56 | 107.33 | 121.91 |
Long-Term Leases | - | - | 0.27 | 0.6 | 1.43 | - |
Total Liabilities | 186.21 | 222.08 | 214.43 | 184.16 | 108.76 | 121.91 |
Common Stock | 133.64 | 102.8 | 77.1 | 77.1 | 77.1 | 73.4 |
Additional Paid-In Capital | 807.8 | 842.45 | 239.32 | 238.83 | 238.25 | 191.24 |
Retained Earnings | 747.04 | 704.25 | 491.13 | 309.02 | 132.7 | 29.41 |
Comprehensive Income & Other | 0.5 | 0.42 | 1.03 | 2.54 | 2.21 | 2.88 |
Shareholders' Equity | 1,689 | 1,650 | 808.58 | 627.49 | 450.26 | 296.92 |
Total Liabilities & Equity | 1,875 | 1,872 | 1,023 | 811.65 | 559.02 | 418.84 |
Total Debt | 1.02 | 0.27 | 0.53 | 2.58 | 2.9 | 28.47 |
Net Cash (Debt) | 760.79 | 957.57 | 227.99 | 146.57 | 67.12 | -3.61 |
Net Cash Growth | 145.43% | 320.00% | 55.55% | 118.37% | - | - |
Net Cash Per Share | 5.33 | 9.54 | 2.27 | 1.46 | 0.70 | -0.04 |
Filing Date Shares Outstanding | 133.64 | 133.64 | 100.23 | 100.23 | 100.23 | 95.42 |
Total Common Shares Outstanding | 133.64 | 133.64 | 100.23 | 100.23 | 100.23 | 95.42 |
Working Capital | 1,132 | 1,156 | 380.72 | 236.87 | 202.56 | 110.24 |
Book Value Per Share | 12.64 | 12.35 | 8.07 | 6.26 | 4.49 | 3.11 |
Tangible Book Value | 1,628 | 1,595 | 752.05 | 569.17 | 392.25 | 276.51 |
Tangible Book Value Per Share | 12.18 | 11.93 | 7.50 | 5.68 | 3.91 | 2.90 |
Buildings | - | 136.57 | 135.44 | 56.68 | 56.19 | 54.67 |
Machinery | - | 197.12 | 171.13 | 153.79 | 147.45 | 108.51 |
Construction In Progress | - | 216.59 | 149.81 | 187.42 | 35.07 | 34.78 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.